Boston Scientific Corp
-
Open
28.93
-
Previous Close
28.89
-
Volume (Avg)
8.66M (7.49M)
-
Day's Range
28.82-29.15
-
52Wk Range
24.54-29.93
-
Market Cap.
39.78B
-
Dividend Rate ( Yield)
-
-
Beta
0.82
-
Shares Outstanding
1.38B
-
P/E Ratio (EPS)
357.14 (0.08)
Top Stories
-
BRIEF-Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences
Reuters 5 days ago* BOSTON SCIENTIFIC CORP - SUCCESSFULLY OPPOSED EDWARDS LIFESCIENCES’ EUROPEAN PATENT EP 2,399,550, RESULTING IN REVOCATION OF PATENT * BOSTON SCIENTIFIC - GERMAN COURT OF APPEAL TO HAVE HEARING IN MAY, JUNE THIS YEAR ABOUT CO’S PATENTS ‘254, ‘766 ...
-
Boston Scientific acquires nVision Medical for up to $275M
Seeking Alpha -
BRIEF-Boston Scientific Announces Acquisition Of NVision Medical Corp
Reuters -
Boston Scientific Acquires NVision Medical In Up To $275 Mln Deal - Quick Facts
Nasdaq -
Boston Scientific : Announces Acquisition Of nVision Medical Corporation
4-Traders 5 days agoMARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health. nVision developed the first and only device cleared by ...
-
Global Nerve Repair & Regeneration Market Overview 2017-2026: Boston Scientific Incorporation
MarketWatch -
Boston Scientific to Acquire Securus Medical, Boost EP Unit
Zacks Investment Research -
Sii Investments Has Trimmed Alibaba Group Hldg LTD (BABA) Position; Boston Scientific (BSX)’s Sentiment Is 1.34
Bibey Post -
Boston Scientific buys Harker School grad's med-tech business for $275M
The Business Journals -
Boston Scientific claims another European patent victory
WBJournal -
Boston Scientific acquires California firm for up to $276M
WBJournal -
European Patent Office revokes Edwards Lifesciences patent in TAVR spat with Boston Scientific
MassDevice -
Boston Scientific buys nVision Medical for $275 million
The Business Journals -
Global Medical Laser Systems Market Competitive landscape: Boston Scientific Corporation
topexaminer.com -
Boston Scientific Corporation: Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences
The Wall Street Transcript 5 days agoFollowing last month's U.K. Court of Appeal's decision confirming that Edwards' Sapien 3™ device infringes the Boston Scientific '766 patent and that all claims of that patent are valid, the U.K. High Court has scheduled a hearing for the week of May 14 ...
-
Boston Scientific Buys Ovarian Cancer Diagnosis Device Maker in $275M Deal
Twin Cities Business -
Boston Scientific acquires NVision Medical in $275m deal
MassDevice -
Global Embolic Protection Devices Market Overview 2017-2026: Boston Scientific Corporation
topexaminer.com
